Citigroup
VXRT

Citigroup’s Vaxart VXRT Stock Holding History

Citigroup’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,464
Closed -$969 – 6003
2024
Q4 		$969 Buy
1,464
+1,461
+48,700% +$1.01K ﹤0.01% 5598
2024
Q3 		$3 Hold
3
– – ﹤0.01% 5644
2024
Q2 		$2 Sell
3
-250,869
-100% -$208K ﹤0.01% 5545
2024
Q1 		$326K Buy
250,872
+250,869
+8,362,300% +$263K ﹤0.01% 3795
2023
Q4 		$2 Hold
3
– – ﹤0.01% 5665
2023
Q3 		$2 Hold
3
– – ﹤0.01% 5642
2023
Q2 		$2 Buy
+3
New +$3 ﹤0.01% 5544
2023
Q1 		– Sell
-952
Closed -$915 – 5898
2022
Q4 		$915 Sell
952
-957,557
-100% -$1.35M ﹤0.01% 5413
2022
Q3 		$2.09M Buy
958,509
+410,644
+75% +$1.42M ﹤0.01% 2106
2022
Q2 		$1.92M Buy
547,865
+385,738
+238% +$1.44M ﹤0.01% 2134
2022
Q1 		$817K Sell
162,127
-498,851
-75% -$2.53M ﹤0.01% 3141
2021
Q4 		$4.14M Buy
660,978
+424,746
+180% +$2.9M ﹤0.01% 1977
2021
Q3 		$1.88M Sell
236,232
-221,119
-48% -$1.82M ﹤0.01% 2597
2021
Q2 		$3.43M Sell
457,351
-150,630
-25% -$1.05M ﹤0.01% 2242
2021
Q1 		$3.68M Buy
607,981
+493,962
+433% +$3.8M ﹤0.01% 2033
2020
Q4 		$651K Buy
114,019
+100,052
+716% +$636K ﹤0.01% 3975
2020
Q3 		$93K Buy
13,967
+7,938
+132% +$70.7K ﹤0.01% 5174
2020
Q2 		$53K Buy
+6,029
New +$17.3K ﹤0.01% 5991
2016
Q2 		– Sell
-14
Closed – – 7475
2016
Q1 		$0 Buy
+14
New +$250 ﹤0.01% 7795
2015
Q4 		– Sell
-2
Closed – – 7893
2015
Q3 		$0 Buy
+2
New +$49 ﹤0.01% 7742
2013
Q4 		– Sell
-5
Closed – – 7173
2013
Q3 		$0 Sell
5
-74
-94% -$3.21K ﹤0.01% 7011
2013
Q2 		$3K Buy
+79
New +$3.28K ﹤0.01% 6465

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's VXRT Position: Q1 2025 in Review

Citigroup sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 1,464 shares — an estimated $969 sold.

Citigroup first reported a position in VXRT in Q2 2013 and held it in 22 quarters. The position peaked at $4.14M in Q4 2021. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • Citigroup reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 1,464 Vaxart shares in Q1 2025, an estimated $969.
  • Citigroup first reported a position in Vaxart in Q2 2013 and held it in 22 quarters.
  • Citigroup's Vaxart position peaked at $4.14M in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.